CAI Q4 2015 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+11.7% YoY

Gross Profit

$13M19.4% margin

Operating Income

-$2M-2.6% margin

Net Income

-$13M-19.2% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

-$47M

Stock-Based Comp.

$479,000

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.5B

Stockholders' Equity

$460M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$59M	+11.7%
Gross Profit	$13M	$38M	-66.9%
Operating Income	-$2M	$25M	-106.8%
Net Income	-$13M	$16M	-177.8%